Overview

Gabapentin in Fibromyalgia Trial (GIFT)

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and effectiveness of the drug gabapentin in reducing pain associated with primary fibromyalgia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Treatments:
Gabapentin
gamma-Aminobutyric Acid